T
Translational Development Acquisition Corp.
TDAC · NASDAQ · Financial Services · 267M
Closing price
$10.82
+0.06% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
29.3×
Price / net assetsP/B
1.1×
Enterprise value / EBITDAEV/EBITDA
-197.9×
Free cash flow yieldFCF yield
-0.3%
Return on equityROE
3.6%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
-0.2×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.